BPC-157 vs TB-500
How the two compare on paper. Both come pre-filled in a pen with a lab report per batch.
| BPC-157 | TB-500 | |
|---|---|---|
| Research area | Recovery | Recovery |
| What it is | Pentadecapeptide gastric juice fragment. | Synthetic thymosin beta-4 active fragment. |
| Researched | for tissue repair | for cell migration |
| Strengths | 10 mg, 10 mg | 10 mg, 10 mg |
| From | AED 125 | AED 95 |
| Price per mg | AED 13/mg | AED 9.5/mg |
| Lab report purity | 99.82% (batch AP26-4418) | 99.61% (batch AP26-4421) |
| What researchers look at | Angiogenic signalling, Fibroblast migration assays, Nitric-oxide pathway | Actin sequestration, Cell migration models, Endothelial differentiation |
Why they are researched together
BPC-157 and TB-500 act through unrelated mechanisms, nitric-oxide-linked angiogenic signalling and actin sequestration. Neither is a stronger version of the other, which is why repair work runs them together rather than choosing between them.